Novel laboratory markers, including pro-inflammatory markers, adipokines, and liver enzymes, may provide a more effective approach for the early diagnosis of metabolic syndrome.
Do novel laboratory markers improve the early diagnosis of metabolic syndrome?
Novel laboratory markers may offer a more effective approach for the early diagnosis of metabolic syndrome compared to traditional criteria.
Metabolic syndrome is prevalent among people all over the world. The unfavorable impact on virtually all organs and tissues of the body and the high incidence of metabolic syndrome make it a relevant medical issue. Since the second half of the 1990s, international health organizations have proposed their criteria for diagnosing metabolic syndrome. However, all proposed criteria had high variability and did not allow for early diagnosis of the syndrome. Evaluation of the novel laboratory markers of metabolic syndrome may prove to be a more effective approach for early diagnosis. In this review, we have systematized the currently known markers and shown the significance of each of them for the diagnosis of metabolic syndrome.
Ayrapetyan et al. (Wed,) conducted a review in Metabolic syndrome. Laboratory markers was evaluated. Novel laboratory markers, including pro-inflammatory markers, adipokines, and liver enzymes, may provide a more effective approach for the early diagnosis of metabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: